BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22554165)

  • 1. Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue.
    Hembrough T; Thyparambil S; Liao WL; Darfler MM; Abdo J; Bengali KM; Taylor P; Tong J; Lara-Guerra H; Waddell TK; Moran MF; Tsao MS; Krizman DB; Burrows J
    Clin Proteomics; 2012 May; 9(1):5. PubMed ID: 22554165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of selected reaction monitoring for multiplex quantification of clinically validated biomarkers in formalin-fixed, paraffin-embedded tumor tissue.
    Hembrough T; Thyparambil S; Liao WL; Darfler MM; Abdo J; Bengali KM; Hewitt SM; Bender RA; Krizman DB; Burrows J
    J Mol Diagn; 2013 Jul; 15(4):454-65. PubMed ID: 23672976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH.
    Catenacci DVT; Liao WL; Zhao L; Whitcomb E; Henderson L; O'Day E; Xu P; Thyparambil S; Krizman D; Bengali K; Uzzell J; Darfler M; Cecchi F; Blackler A; Bang YJ; Hart J; Xiao SY; Lee SM; Burrows J; Hembrough T
    Gastric Cancer; 2016 Oct; 19(4):1066-1079. PubMed ID: 26581548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute quantitation of Met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue.
    Catenacci DV; Liao WL; Thyparambil S; Henderson L; Xu P; Zhao L; Rambo B; Hart J; Xiao SY; Bengali K; Uzzell J; Darfler M; Krizman DB; Cecchi F; Bottaro DP; Karrison T; Veenstra TD; Hembrough T; Burrows J
    PLoS One; 2014; 9(7):e100586. PubMed ID: 24983965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non-Small Cell Lung Cancer Tissues from Patients Treated with Crizotinib.
    Hembrough T; Liao WL; Hartley CP; Ma PC; Velcheti V; Lanigan C; Thyparambil S; An E; Monga M; Krizman D; Burrows J; Tafe LJ
    Clin Chem; 2016 Jan; 62(1):252-61. PubMed ID: 26585927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel proximity assay for the detection of proteins and protein complexes: quantitation of HER1 and HER2 total protein expression and homodimerization in formalin-fixed, paraffin-embedded cell lines and breast cancer tissue.
    Shi Y; Huang W; Tan Y; Jin X; Dua R; Penuel E; Mukherjee A; Sperinde J; Pannu H; Chenna A; DeFazio-Eli L; Pidaparthi S; Badal Y; Wallweber G; Chen L; Williams S; Tahir H; Larson J; Goodman L; Whitcomb J; Petropoulos C; Winslow J
    Diagn Mol Pathol; 2009 Mar; 18(1):11-21. PubMed ID: 19214113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures.
    Wei Y; Tong J; Taylor P; Strumpf D; Ignatchenko V; Pham NA; Yanagawa N; Liu G; Jurisica I; Shepherd FA; Tsao MS; Kislinger T; Moran MF
    J Proteome Res; 2011 Jan; 10(1):161-74. PubMed ID: 20815376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA).
    Bader S; Zajac M; Friess T; Ruge E; Rieder N; Gierke B; Heubach Y; Thomas M; Pawlak M
    Mol Cell Proteomics; 2015 Oct; 14(10):2775-85. PubMed ID: 26106084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision of multiple reaction monitoring mass spectrometry analysis of formalin-fixed, paraffin-embedded tissue.
    Sprung RW; Martinez MA; Carpenter KL; Ham AJ; Washington MK; Arteaga CL; Sanders ME; Liebler DC
    J Proteome Res; 2012 Jun; 11(6):3498-505. PubMed ID: 22530795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.
    Nitta H; Kelly BD; Padilla M; Wick N; Brunhoeber P; Bai I; Singh S; Ranger-Moore J; Bieniarz C; Tsuda H; Grogan TM
    Diagn Pathol; 2012 May; 7():60. PubMed ID: 22647525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Highly Multiplexed SRM Assay for Biomarker Discovery in Formalin-Fixed Paraffin-Embedded Tissues.
    Steiner C; Lescuyer P; Tille JC; Cutler P; Ducret A
    Methods Mol Biol; 2019; 1959():185-203. PubMed ID: 30852824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues.
    Steiner C; Tille JC; Lamerz J; Kux van Geijtenbeek S; McKee TA; Venturi M; Rubbia-Brandt L; Hochstrasser D; Cutler P; Lescuyer P; Ducret A
    Mol Cell Proteomics; 2015 Oct; 14(10):2786-99. PubMed ID: 26149442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-Time Reverse-Transcription Quantitative Polymerase Chain Reaction Assay Is a Feasible Method for the Relative Quantification of Heregulin Expression in Non-Small Cell Lung Cancer Tissue.
    Kristof J; Sakrison K; Jin X; Nakamaru K; Schneider M; Beckman RA; Freeman D; Spittle C; Feng W
    Biomark Insights; 2017; 12():1177271917699850. PubMed ID: 28469400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR family and cMet expression profiles and prognostic significance in esophagogastric adenocarcinoma.
    Chan E; Alkhasawneh A; Duckworth LV; Aijaz T; Toro TZ; Lu X; Hughes SJ; Collinsworth A; George TJ
    J Gastrointest Oncol; 2016 Dec; 7(6):838-847. PubMed ID: 28078108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR Mutational Profiling in Non-Small Cell Lung Cancer: The Clinical Performance of a Sensitive Reverse-Hybridization Assay.
    Kriegshäuser G; Enko D; Novy M; Reitmayr A; Loidl A; Halwachs-Baumann G; Oberkanins C
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):388-392. PubMed ID: 27801728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 17. [A standardized protocol for detection of ALK protein expression and gene fusion in lung adenocarcinoma cytologic specimens].
    Wang Z; Wu X; Shi Y; Han X; Cheng G; Li L; Mu X; Zhang Y; Cui D; Zhang L; Fan Z; Zhu G; Ma L; Yang L; Di J; Liu D
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):742-8. PubMed ID: 26813592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of epidermal growth factor receptor gene T790M mutation in cytology samples using the cobas
    Satouchi M; Tanaka H; Yoshioka H; Shimokawaji T; Mizuno K; Takeda K; Yoshino I; Seto T; Kurata T; Tashiro N; Hagiwara K
    Lung Cancer; 2017 Sep; 111():190-194. PubMed ID: 28838392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).
    Reynolds JP; Tubbs RR; Minca EC; MacNamara S; Almeida FA; Ma PC; Pennell NA; Cicenia JC
    Lung Cancer; 2014 Nov; 86(2):158-63. PubMed ID: 25263855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of bronchial lavage fluids for epithelial growth factor receptor mutation assay in lung cancer patients: Comparison between cell pellets, cell blocks and matching tissue specimens.
    Asaka S; Yoshizawa A; Nakata R; Negishi T; Yamamoto H; Shiina T; Shigeto S; Matsuda K; Kobayashi Y; Honda T
    Oncol Lett; 2018 Feb; 15(2):1469-1474. PubMed ID: 29399190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.